Human Genome Epidemiology Literature Finder
|
Records 1 - 12 (of 12 Records) |
| Query Trace: DNA Damage and RAD51D[original query] |
|---|
| Prevalence of Germline Mutations in Genes Engaged in DNA Damage Repair by Homologous Recombination in Patients with Triple-Negative and Hereditary Non-Triple-Negative Breast Cancers. PloS one 2015 10 (6): e0130393. Domagala Pawel, Jakubowska Anna, Jaworska-Bieniek Katarzyna, Kaczmarek Katarzyna, Durda Katarzyna, Kurlapska Agnieszka, Cybulski Cezary, Lubinski J |
| Addition of triple negativity of breast cancer as an indicator for germline mutations in predisposing genes increases sensitivity of clinical selection criteria. BMC cancer 2018 Sep 18 (1): 926. Hoyer Juliane, Vasileiou Georgia, Uebe Steffen, Wunderle Marius, Kraus Cornelia, Fasching Peter A, Thiel Christian T, Hartmann Arndt, Beckmann Matthias W, Lux Michael P, Reis And |
| Association between polymorphisms in MicroRNA target sites of RAD51D genes and risk of hepatocellular carcinoma. Cancer medicine 2019 Mar . Jiang Yan-Ji, Zhong Jian-Hong, Zhou Zi-Han, Qiu Mo-Qin, Zhou Xian-Guo, Liu Ying-Chun, Huo Rong-Rui, Liang Xiu-Mei, Chen Zhu, Lin Qiu-Ling, Yu Xiang-Yuan, Yu Hong-Pi |
| Mutations in DNA Repair Genes and Clinical Outcomes of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin or Irinotecan-containing Regimens. American journal of clinical oncology 2020 Dec . Marks Eric I, Matera Robert, Olszewski Adam J, Yakirevich Evgeny, El-Deiry Wafik S, Safran Howard, Carneiro Benedito |
| Genomic Analysis Reveals Novel Specific Metastatic Mutations in Chinese Clear Cell Renal Cell Carcinoma. BioMed research international 2020 2020 2495157. Meng Hui, Jiang Xuewen, Cui Jianfeng, Yin Gang, Shi Benkang, Liu Qi, Xuan He, Wang |
| Characteristics of Germline Non-BRCA Mutation Status of High-Risk Breast Cancer Patients in China and Correlation with High-Risk Factors and Multigene Testing Suggestions. Frontiers in genetics 2021 12 12 674094. Su Yifan, Yao Qianlan, Xu Yuyin, Yu Chengli, Zhang Jing, Wang Qian, Li Jiwei, Shi Di, Yu Baohua, Zeng Yupeng, Zhu Xiaoli, Bai Qianming, Zhou Xiaoy |
| Prevalence and Spectrum of Predisposition Genes With Germline Mutations Among Chinese Patients With Bowel Cancer. Frontiers in genetics 2022 2 12 755629. Xie Zhengyong, Ke Yongli, Chen Junyong, Li Zehang, Wang Changzheng, Chen Yuhong, Ding Hongliang, Cheng Liya |
| Prevalence of Germline Sequence Variations Among Patients With Pancreatic Cancer in China. JAMA network open 2022 02 5 (2): e2148721. Yin Lingdi, Wei Jishu, Lu Zipeng, Huang Shimeng, Gao Hao, Chen Jianmin, Guo Feng, Tu Min, Xiao Bin, Xi Chunhua, Zhang Kai, Li Qiang, Wu Junli, Gao Wentao, Jiang Kuirong, Yu Jun, Miao |
| Comprehensive Analysis of the Expression and Prognosis for RAD51 Family in Human Breast Cancer. International journal of general medicine 2022 15 4925-4936. Shi Yaqin, Shen Meng, Xu Mengdan, Tao Min, Chen Kai, Zhu Qingqi |
| Ovarian High-grade Serous Carcinoma with Transitional-like (SET) Morphology: A Homologous Recombination-deficient Tumor. Human pathology 2023 9 . Emanuela D'Angelo, Iñigo Espinosa, Lara Felicioni, Fiamma Buttitta, Jaime Pr |
| Next generation sequencing reveals a high prevalence of pathogenic mutations in homologous recombination DNA damage repair genes among patients with uterine sarcoma. Gynecologic oncology 2023 8 177 14-19. Dimitrios Nasioudis, Nawar A Latif, Emily M Ko, Lori Cory, Sarah H Kim, Lainie Martin, Fiona Simpkins, Robert Giunto |
| Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer. Human genomics 2023 7 17 (1): 66. Ning-Yuan Lee, Melissa Hum, Sabna Zihara, Lanying Wang, Matthew K Myint, Darren Wan-Teck Lim, Chee-Keong Toh, Anders Skanderup, Jens Samol, Min-Han Tan, Peter Ang, Soo-Chin Lee, Eng-Huat Tan, Gillianne G Y Lai, Daniel S W Tan, Yoon-Sim Yap, Ann S G L |
- Page last reviewed:Oct 1, 2023
- Page last updated:Nov 30, 2023
- Content source: